Targeting EGFR for Treatment of Glioblastoma: Molecular Basis to Overcome Resistance

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|12|3|197-209

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.12, Iss.3, 2012-01, pp. : 197-209

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic targeting of EGFR-activated metabolic pathways in glioblastoma

By Gao Qinglei  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 8, 2013-08 ,pp. : 1023-1040

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic targeting of VEGF in the treatment of glioblastoma

By Robles Irizarry Lizbeth   Hambardzumyan Dolores   Nakano Ichiro   Gladson Candece L   Ahluwalia Manmeet S  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 10, 2012-10 ,pp. : 973-984

Informa Healthcare

Access to resources Recommend Favorite

Structural Basis for Drug Resistance Mechanisms Against EGFR

By  

Current Topics in Medicinal Chemistry, Vol. 17, Iss. 22, 2017-07 ,pp. : 2509-2521

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting AMPK Signaling Pathway to Overcome Drug Resistance for Cancer Therapy

By  

Current Drug Targets, Vol. 17, Iss. 8, 2016-06 ,pp. : 853-864

Bentham Science Publishers

Access to resources Recommend Favorite

Immunoliposomal delivery of doxorubicin can overcome multidrug resistance mechanisms in EGFR-overexpressing tumor cells

By Mamot Christoph   Ritschard Reto   Wicki Andreas   Küng Willy   Schuller Jan   Herrmann Richard   Rochlitz Christoph  

Journal of Drug Targeting, Vol. 20, Iss. 5, 2012-06 ,pp. : 422-432

Informa Healthcare

Access to resources Recommend Favorite